Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults

This publication has 20 references indexed in Scilit:

• Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012–2013
  Clinical Infectious Diseases, 2015
• Human Influenza A Virus–Specific CD8+ T-Cell Response Is Long-lived
  The Journal of Infectious Diseases, 2015
• Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
  Molecular Therapy, 2014
• Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
  Molecular Therapy, 2014
• Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
  Nature Medicine, 2012
• Characterization of the Human CD8⁺T Cell Response following Infection with 2009 Pandemic Influenza H1N1 Virus
  Journal of Virology, 2011
• Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
  Clinical Infectious Diseases, 2011
• Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines—a retrospective analysis of three independent field trials
  Journal of Immunological Methods, 2002
• DECLINING T-CELL IMMUNITY TO INFLUENZA, 1977-82
  The Lancet, 1983
• Cytotoxic T-Cell Immunity to Influenza
  New England Journal of Medicine, 1983